This multi-country project is catalyzing the introduction and adoption pathways for quality-assured drugs to treat postpartum hemorrhage (i.e., heat-stable carbetocin, tranexamic acid and misoprostol) through engagement and coordination with country governments and key stakeholders. The project aims to reduce maternal mortality and morbidity by making sure the right drug is in the right place at the right time for the right indication. Funded by Unitaid, AMPLI-PPHI is led by Jhpiego and supported by consortium partners PATH and the International Federation of Gynaecology and Obstetrics (FIGO). In addition to operating in four target countries (the Democratic Republic of Congo, Guinea, Kenya and India), an additional 13 other influence countries are benefitting from country and learning exchanges as well as from the sharing of project learning, resources and tools. For more information, please visit the project website.

The U.S. President’s Emergency Plan for AIDS Relief, has delivered remarkable lifesaving results, with several countries approaching UNAIDS 95-95-95 goals for HIV epidemic control. As countries like DRC come closer to their targets, challenges to close the remaining gaps and cross the “last mile” become more difficult, requiring innovative, targeted approaches to ensure equity and extend services to the hardest-to reach populations and underserved areas. Global Reach II is a five-year project that supports the delivery of effective solutions to address these challenges in country-level HIV responses, adapting to the country contexts. Funded through the U.S. Health Resources and Services Administration (HRSA), Jhpiego leads the project with the following partners: University of California San Francisco, International Treatment Preparedness Coalition, Project ECHO, African Forum for Research and Education in Health (AFREhealth), Johns Hopkins University Center for Global Health and Ata Health Strategies. In DRC, this project is supporting pre-service education institutions and responsible government ministries to ensure that nurses in particular are well prepared to provide HIV and maternal and newborn health services in their communities. The project is also working with the National Order of Nurses on implementation of a 2016 law creating a system of registration and regulation of nursing cadres.

Under this two-year project funded by the Bill & Melinda Gates Foundation, Jhpiego is providing continuous technical assistance in the introduction and scale-up of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) in Benin, the Democratic Republic of Congo and Togo. Also known as Sayana® Press, DMPA-SC is an innovative injectable contraceptive that can be self-injected and has the potential to dramatically expand family planning access and choice when offered as part of a broad method mix. In addition to seeking to make DMPA-SC, including self-injection, more available in the three countries, the project aims to ensure provision of technical assistance, knowledge sharing, data tools, research findings and other resources to enable more than 30 countries to introduce and scale up DMPA-SC and self-injection.